Diagnosis and treatment of aspiration pneumonia;Diagnostik und therapie der aspirationspneumonie

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 12, 2006, Pages 624-628

  Ott, Sebastian R ^a   Lode, H ^b  

^a HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^b Research Center for Medical Studies (RCMS)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM;

ANTIBIOTIC THERAPY; ASPIRATION PNEUMONIA; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; PNEUMONIA, ASPIRATION; PNEUMONIA, BACTERIAL; RADIOGRAPHY, THORACIC;

EID: 33645550878     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933707     Document Type: Review

References (15)

1. Allewelt M, Schüler P, Lode H et al. Ampicillin + sulbactam vs. clindamycin (cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect 2004; 10: 163-170
2. Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975; 68: 560-566
3. Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91: 901-909
4. El-Solh AA, Pietrantoni C, Bhat A et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167: 1650-1654
5. Grinan NP, Lucena FM, Romero JV et al. Yield of percutaneous needle lung aspiration in lung abcsess. Chest 1990; 97: 69-74
6. Haber P et al. Fatal lung abscesses: review of 11 years experience. South Med J 1981; 74: 281-283
7. Hagan J et al. Lung abscess revisited: a survey of 184 cases. Ann Surg 1983; 197: 755-62
8. Höffken G, Lorenz J, Kern T et al. S3-Leitlinie zu ambulant erworbener Pneumonie und tiefen Atemwegsinfektionen. Pneumologie 2005; 59: 612-664
9. Huxley EJ, Viroslav J, Gray WR et al. Pharyngeal Aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64: 564-568
10. Levinson ME, Mangura CT, Lorber B et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983: 98: 466-471
11. Lorber B, Swenson RM. Bacteriology of aspiration pneumonia: a prospective study of community- and hospital-acquired cases. Ann Intern Med 1974; 81: 329-331
12. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospilatisation: 5-year prospective study. Rev Infect Dis 1989; 11: 586-599
13. Mundy LM, Auwaerter PG, Oldach D et al. Comunnity-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152: 1309-1315
14. Ott SR, Allewelt M, Lode H et al. A novel approach in the treatment of aspiration pneumonia and primary lung abscess. Oral Presentation, ERS 15th Annual Congress, Copenhagen, September 17-21, 2005, 2005
15. Perlino CA. Metronidazole vs clindamycin treatment of anaerobic pulmonary infection: failure of metronidazole therapy. Arch Intern Med 1981; 141: 1424-1427